WashU Medicine initiates groundbreaking international trial testing Eli Lilly's remternetug in young adults as young as 18, targeting Alzheimer's prevention up to 25 years before expected symptom onset.
Ionis Pharmaceuticals reports positive progress across its pipeline, highlighted by the U.S. launch of WAINUA and advancements in regulatory approvals.